Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal.


Journal

Cancer research
ISSN: 1538-7445
Titre abrégé: Cancer Res
Pays: United States
ID NLM: 2984705R

Informations de publication

Date de publication:
01 Dec 2023
Historique:
received: 30 03 2023
revised: 24 05 2023
accepted: 30 08 2023
medline: 4 12 2023
pubmed: 5 9 2023
entrez: 5 9 2023
Statut: ppublish

Résumé

International cancer registries make real-world genomic and clinical data available, but their joint analysis remains a challenge. AACR Project GENIE, an international cancer registry collecting data from 19 cancer centers, makes data from >130,000 patients publicly available through the cBioPortal for Cancer Genomics (https://genie.cbioportal.org). For 25,000 patients, additional real-world longitudinal clinical data, including treatment and outcome data, are being collected by the AACR Project GENIE Biopharma Collaborative using the PRISSMM data curation model. Several thousand of these cases are now also available in cBioPortal. We have significantly enhanced the functionalities of cBioPortal to support the visualization and analysis of this rich clinico-genomic linked dataset, as well as datasets generated by other centers and consortia. Examples of these enhancements include (i) visualization of the longitudinal clinical and genomic data at the patient level, including timelines for diagnoses, treatments, and outcomes; (ii) the ability to select samples based on treatment status, facilitating a comparison of molecular and clinical attributes between samples before and after a specific treatment; and (iii) survival analysis estimates based on individual treatment regimens received. Together, these features provide cBioPortal users with a toolkit to interactively investigate complex clinico-genomic data to generate hypotheses and make discoveries about the impact of specific genomic variants on prognosis and therapeutic sensitivities in cancer. Enhanced cBioPortal features allow clinicians and researchers to effectively investigate longitudinal clinico-genomic data from patients with cancer, which will improve exploration of data from the AACR Project GENIE Biopharma Collaborative and similar datasets.

Identifiants

pubmed: 37668528
pii: 728880
doi: 10.1158/0008-5472.CAN-23-0816
pmc: PMC10690089
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3861-3867

Subventions

Organisme : NCI NIH HHS
ID : U24 CA274633
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCRR NIH HHS
ID : P41 RR031228
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA233243
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA264028
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA143840
Pays : United States

Informations de copyright

©2023 The Authors; Published by the American Association for Cancer Research.

Références

JAMA Oncol. 2022 Feb 01;8(2):287-291
pubmed: 34734967
Cancer Discov. 2017 Aug;7(8):818-831
pubmed: 28572459
JCO Clin Cancer Inform. 2021 Feb;5:221-230
pubmed: 33625877
JCO Precis Oncol. 2017 Jul;2017:
pubmed: 28890946
Nat Med. 2017 Jun;23(6):703-713
pubmed: 28481359
Clin Cancer Res. 2023 Sep 1;29(17):3418-3428
pubmed: 37223888
Cell. 2018 Apr 5;173(2):291-304.e6
pubmed: 29625048
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Cancer Discov. 2018 Feb;8(2):174-183
pubmed: 29247016
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Nucleic Acids Res. 2017 Jan 4;45(D1):D840-D845
pubmed: 27899611
JCO Clin Cancer Inform. 2021 Sep;5:995-1004
pubmed: 34554823
Clin Cancer Res. 2012 Mar 1;18(5):1472-82
pubmed: 22235099
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Nat Genet. 2017 Jan 31;49(2):170-174
pubmed: 28138153
JCO Clin Cancer Inform. 2022 Feb;6:e2100144
pubmed: 35148171
JCO Clin Cancer Inform. 2022 Feb;6:e2100105
pubmed: 35192403

Auteurs

Ino de Bruijn (I)

Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Ritika Kundra (R)

Memorial Sloan Kettering Cancer Center, New York, New York.

Brooke Mastrogiacomo (B)

Memorial Sloan Kettering Cancer Center, New York, New York.

Thinh Ngoc Tran (TN)

Memorial Sloan Kettering Cancer Center, New York, New York.

Luke Sikina (L)

Dana-Farber Cancer Institute, Boston, Massachusetts.

Tali Mazor (T)

Dana-Farber Cancer Institute, Boston, Massachusetts.

Xiang Li (X)

Memorial Sloan Kettering Cancer Center, New York, New York.

Angelica Ochoa (A)

Memorial Sloan Kettering Cancer Center, New York, New York.

Gaofei Zhao (G)

Memorial Sloan Kettering Cancer Center, New York, New York.

Bryan Lai (B)

Memorial Sloan Kettering Cancer Center, New York, New York.

Adam Abeshouse (A)

Memorial Sloan Kettering Cancer Center, New York, New York.

Diana Baiceanu (D)

The Hyve, Utrecht, the Netherlands.

Ersin Ciftci (E)

Dana-Farber Cancer Institute, Boston, Massachusetts.

Ugur Dogrusoz (U)

Bilkent University, Ankara, Turkey.

Andrew Dufilie (A)

Dana-Farber Cancer Institute, Boston, Massachusetts.

Ziya Erkoc (Z)

Dana-Farber Cancer Institute, Boston, Massachusetts.

Elena Garcia Lara (E)

The Hyve, Utrecht, the Netherlands.

Zhaoyuan Fu (Z)

Dana-Farber Cancer Institute, Boston, Massachusetts.

Benjamin Gross (B)

Memorial Sloan Kettering Cancer Center, New York, New York.

Charles Haynes (C)

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Allison Heath (A)

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

David Higgins (D)

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Prasanna Jagannathan (P)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Karthik Kalletla (K)

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Priti Kumari (P)

Dana-Farber Cancer Institute, Boston, Massachusetts.
Caris Life Sciences, Irving, Texas.

James Lindsay (J)

Dana-Farber Cancer Institute, Boston, Massachusetts.

Aaron Lisman (A)

Memorial Sloan Kettering Cancer Center, New York, New York.

Bas Leenknegt (B)

The Hyve, Utrecht, the Netherlands.

Pieter Lukasse (P)

The Hyve, Utrecht, the Netherlands.

Divya Madela (D)

Memorial Sloan Kettering Cancer Center, New York, New York.

Ramyasree Madupuri (R)

Memorial Sloan Kettering Cancer Center, New York, New York.

Pim van Nierop (P)

The Hyve, Utrecht, the Netherlands.

Oleguer Plantalech (O)

The Hyve, Utrecht, the Netherlands.

Joyce Quach (J)

Dana-Farber Cancer Institute, Boston, Massachusetts.

Adam C Resnick (AC)

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Sander Y A Rodenburg (SYA)

The Hyve, Utrecht, the Netherlands.

Baby A Satravada (BA)

Memorial Sloan Kettering Cancer Center, New York, New York.

Fedde Schaeffer (F)

The Hyve, Utrecht, the Netherlands.

Robert Sheridan (R)

Memorial Sloan Kettering Cancer Center, New York, New York.

Jessica Singh (J)

The Hyve, Utrecht, the Netherlands.

Rajat Sirohi (R)

Dana-Farber Cancer Institute, Boston, Massachusetts.

Selcuk Onur Sumer (SO)

Memorial Sloan Kettering Cancer Center, New York, New York.

Sjoerd van Hagen (S)

The Hyve, Utrecht, the Netherlands.

Avery Wang (A)

Memorial Sloan Kettering Cancer Center, New York, New York.

Manda Wilson (M)

Memorial Sloan Kettering Cancer Center, New York, New York.

Hongxin Zhang (H)

Memorial Sloan Kettering Cancer Center, New York, New York.

Kelsey Zhu (K)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Nicole Rusk (N)

Memorial Sloan Kettering Cancer Center, New York, New York.

Samantha Brown (S)

Memorial Sloan Kettering Cancer Center, New York, New York.

Jessica A Lavery (JA)

Memorial Sloan Kettering Cancer Center, New York, New York.

Katherine S Panageas (KS)

Memorial Sloan Kettering Cancer Center, New York, New York.

Julia E Rudolph (JE)

Memorial Sloan Kettering Cancer Center, New York, New York.

Michele L LeNoue-Newton (ML)

Vanderbilt University Medical Center, Nashville, Tennessee.

Jeremy L Warner (JL)

Brown University, Providence, Rhode Island.

Xindi Guo (X)

Sage Bionetworks, Seattle, Washington.

Haley Hunter-Zinck (H)

Sage Bionetworks, Seattle, Washington.

Thomas V Yu (TV)

Sage Bionetworks, Seattle, Washington.

Shirin Pilai (S)

Memorial Sloan Kettering Cancer Center, New York, New York.

Chelsea Nichols (C)

Memorial Sloan Kettering Cancer Center, New York, New York.

Stuart M Gardos (SM)

Memorial Sloan Kettering Cancer Center, New York, New York.

John Philip (J)

Memorial Sloan Kettering Cancer Center, New York, New York.

Kenneth L Kehl (KL)

Dana-Farber Cancer Institute, Boston, Massachusetts.

Gregory J Riely (GJ)

Memorial Sloan Kettering Cancer Center, New York, New York.

Deborah Schrag (D)

Memorial Sloan Kettering Cancer Center, New York, New York.

Jocelyn Lee (J)

American Association for Cancer Research: Project GENIE, Philadelphia, Pennsylvania.

Michael V Fiandalo (MV)

American Association for Cancer Research: Project GENIE, Philadelphia, Pennsylvania.

Shawn M Sweeney (SM)

American Association for Cancer Research: Project GENIE, Philadelphia, Pennsylvania.

Trevor J Pugh (TJ)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Chris Sander (C)

Harvard Medical School, Boston, Massachusetts.

Ethan Cerami (E)

Dana-Farber Cancer Institute, Boston, Massachusetts.

Jianjiong Gao (J)

Memorial Sloan Kettering Cancer Center, New York, New York.
Caris Life Sciences, Irving, Texas.

Nikolaus Schultz (N)

Memorial Sloan Kettering Cancer Center, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH